ANI Pharmaceuticals, Inc. (ANIP)
81.18
+1.06
(+1.32%)
USD |
NASDAQ |
Jun 09, 16:00
81.18
0.00 (0.00%)
After-Hours: 17:53
ANI Pharmaceuticals SG&A Expense (Quarterly) : 73.66M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 124.00M |
| Liquidia Corp. | 46.94M |
| Phathom Pharmaceuticals, Inc. | 54.01M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| AbbVie, Inc. | 3.578B |